0000950170-23-028606.txt : 20230616 0000950170-23-028606.hdr.sgml : 20230616 20230616160924 ACCESSION NUMBER: 0000950170-23-028606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lloyd Marcea Bland CENTRAL INDEX KEY: 0001389208 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39376 FILM NUMBER: 231021142 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DRIVE STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Poseida Therapeutics, Inc. CENTRAL INDEX KEY: 0001661460 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 472846548 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-779-3100 MAIL ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 ownership.xml 4 X0407 4 2023-06-15 false 0001661460 Poseida Therapeutics, Inc. PSTX 0001389208 Lloyd Marcea Bland C/O POSEIDA THERAPEUTICS, INC. 9390 TOWNE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121 true false false false false Common Stock 2023-06-15 4 A false 19650 0.00 A 49300 D Stock Option (Right to buy) 2.47 2023-06-15 4 A false 27350 0.00 A 2033-06-14 Common Stock 27350 27350 D Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders. The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders. /s/ Harry J.Leonhardt, Attorney-in-Fact 2023-06-16